Minimal residual disease was “strongly” associated with overall survival at the patient level, researchers reported. Minimal residual disease (MRD) is “a credible intermediate endpoint” for some ...
Clinicians have long relied on clinical risk factors, imaging, and pathology to guide cancer surveillance and adjuvant treatment. However, even after curative-intent surgery and definitive therapy, ...
TORONTO -- Achieving minimal residual disease (MRD) negativity was associated with favorable safety outcomes and no effect on health-related quality of life among patients with newly diagnosed ...
Personalis has high upside potential if its MRD test gains Medicare reimbursement, but current revenue and margins are under pressure. The company faces declining pharma revenue, sustained cash burn, ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for identifying patients ...
An Android phone will be locked after erasing data and factory resetting. It will ask for the Google account and password if you want to get full access to his phone. That is FRP. What is FRP meaning?
Management reaffirmed that the ALPHA3 futility analysis and MRD conversion data will be shared in the first half of 2026. The company expects 2025 cash burn of approximately $150 million and full-year ...
ROCHESTER, N.Y., Aug. 12, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered smart glasses, waveguides and Augmented Reality (AR) ...
AUSTIN, Texas, July 07, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal cancer (CRC) study of its ...
Liquid biopsies are rapidly becoming an essential tool for monitoring minimal residual disease (MRD) in cancer treatment. Analyzing cell-free DNA (cfDNA) allows for the detection of tumor-specific ...
MILAN — The landscape of hematologic malignancies is shifting rapidly, in part due to the evolving significance of measurable (formerly "minimal") residual disease (MRD). Once confined to the realm of ...
Adaptive Biotechnologies Corporation announced that its clonoSEQ® test for measurable residual disease (MRD) will be prominently featured in 30 presentations at the upcoming American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback